Document:

Rule 10b5-1 Trading Plan

 Exhibit 10.2 
 

 
 Rule 10b5-1 Trading Plan 
 John D. Held (“Seller”) adopts this Trading Plan dated 8/31, 2007 (the “Trading Plan”) with respect to the “Stock” (defined below) with UBS Financial Services Inc. for the purpose of
establishing a trading plan that complies with Rule 10b5-l(c)(l) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). 
 Seller and UBS Financial Services Inc. agree as follows: 
  

	1.	Specific Plan of Sale. UBS Financial Services Inc., acting as agent, agrees to effect sales of Stock on behalf of Seller in accordance with the specific instructions
set forth in Exhibit A (the “Sales Instructions”). The term “Stock” means the common stock, par value $0.01 per share, of Omega Protein Corporation (“Issuer”) (symbol: OME), including Stock that Seller has the right to
acquire under the outstanding stock options issued by Issuer listed on Exhibit D (the “Options”), and includes any class or series of common stock of Issuer into which the Stock is converted whether pursuant to a reclassification,
reorganization, reincorporation or similar event. 

  

	2.	Fees/Commissions. Seller shall pay UBS Financial Services Inc. $0.05 per share of Stock sold; with such amounts to be deducted by UBS Financial Services Inc. from the
proceeds of sales under this Trading Plan. 

  

	3.	Seller’s Representations and Warranties. Seller represents and warrants that: 

  

	 	(a)	Seller is not aware of any material nonpublic information concerning Issuer or any securities of Issuer; 

  

	 	(b)	Seller is entering into this Trading Plan in good faith and not as part of a plan or scheme to evade the prohibitions of Rule 10b5-l; 

  

	 	(c)	Seller has informed Issuer of this Trading Plan and has furnished Issuer with a copy, and Seller has determined that this Trading Plan is consistent with Issuer’s insider
trading policy; 

  

	 	(d)	Seller has disclosed to UBS Financial Services Inc. any agreements that Seller is currently party to, or within the past 60 days, has been party to, with another broker, dealer or
financial institution (each, a “Financial Institution”) entered into for the purpose of establishing a trading plan that complies with Rule 10b5-l; 

  

	 	(e)	Seller is not subject to any legal, regulatory or contractual restriction or undertaking that would prevent UBS Financial Services Inc. from conducting sales in accordance with this
Trading Plan; 

  

	 	(f)	the Stock to be sold under this Trading Plan is owned free and clear by Seller and is not subject to any liens, security interests or other encumbrances or limitations on
dispositions, other than those imposed by Rule 144 or Rule 145, if applicable; 

  

	 	(g)	Seller has had an opportunity to consult with Seller’s own advisors as to the legal, tax, financial and other aspects of this Trading Plan, including this Trading Plan’s
compliance with Rule 10b5-l and applicable state law. Seller has not received or relied on any representations from UBS Financial Services Inc. concerning this Trading Plan’s compliance with Rule l0b5-l. 

 © UBS Financial Services Inc. 2001-2004

	4.	Agreements by Seller. Seller acknowledges and agrees to the following provisions: 

  

	 	(a)	Brokerage Account. Seller shall open a sole-purpose UBS Financial Services Inc. brokerage account prior to the execution of sales under this Trading Plan in the name
of and for the benefit of Seller (the “Plan Account”). 

  

	 	(b)	Delivery of Stock. Seller shall deliver all shares of Stock to be sold pursuant to this Trading Plan into the Plan Account prior to the commencement of any sales under
this Trading Plan. 

  

	 	(c)	Hedging Transactions. While this Trading Plan is in effect, Seller shall comply with the prohibition set forth in Rule 10b5-l(c)(l)(i)(C) against entering into or
altering a corresponding or hedging transaction or position with respect to the Stock. 

  

	 	(d)	Notice to UBS Financial Services Inc.. Seller shall notify UBS Financial Services Inc. to terminate or suspend sales, as appropriate, as soon as practicable upon the
occurrence of any of the events contemplated in paragraph 7(a) or (b) or paragraph 8(c). 

  

	 	(e)	Communications. Seller shall not, directly or indirectly, communicate any material nonpublic information relating to the Stock or Issuer to any employee of the UBS
Financial Services Inc. 10b5-l Group or any UBS Financial Services Inc. Financial Advisor. 

  

	 	(f)	Compliance with Applicable Laws and Required Exchange Act Filings. Seller shall comply with all applicable laws, rules and regulations, and Seller shall make all
filings required under Sections 13 and 16 of the Exchange Act in a timely manner. 

  

	 	(g)	No Influence. Seller does not have, and shall not attempt to exercise, any influence over how, when or whether to effect sales of Stock pursuant to this Trading Plan.

  

	 	(h)	Stock Non-Marginable. The Stock is not marginable and may not be used by Seller as collateral for any purpose. 

  

	 	(i)	 Execution, Average Pricing and Pro Rata Allocation of Sales. UBS Financial Services Inc. may sell Stock on any national securities exchange, in the
over-the-counter market, on an automated trading system or otherwise. UBS Financial Services Inc. or one of its affiliates may make a market in the Stock and may act as principal in executing sales under the Trading Plan. To the extent that UBS
Financial Services Inc. administers other trading plans relating to Issuer’s securities, UBS Financial Services Inc. may aggregate orders for Seller with orders under other sellers’ trading plans for execution in a block and allocate each
execution on a pro rata basis to each seller. In the event of partial execution of block orders, UBS Financial Services Inc. shall allocate the proceeds of all Stock actually sold on a particular day pursuant to all Rule 10b5-l trading plans
concerning Issuer’s securities that UBS Financial Services Inc. manages pro rata 

  

 2 

	 	 
based on the ratio of (x) the number of shares to be sold pursuant to the order instructions of each Trading Plan to (y) the total number of shares
to be sold under all Trading Plans having the same type of order instructions. 

  

	 	(j)	Exclusivity. Until this Trading Plan has been terminated, Seller shall not enter into any agreement with, give any instructions to, or adopt a plan for trading with
another Financial Institution with respect to purchase or sale of the Stock or the Options for the purpose of establishing a trading plan that complies with Rule 10b5-l. 

  

	 	(k)	Acknowledgment of Relief from Obligation to Effect Sales. UBS Financial Services Inc. shall be relieved of its obligation to sell Stock as otherwise required by
paragraph 1 above at any time when: 

  

	 	(i)	UBS Financial Services Inc. has determined that (A) it is prohibited from doing so by a legal, contractual or regulatory restriction applicable to it or its affiliates or to
Seller or Seller’s affiliates; or (B) a material adverse change in the financial markets, in the market activity in the Stock or in the internal systems of UBS Financial Services Inc. or one of its affiliates, an outbreak or escalation of
hostilities or other crisis or calamity has occurred (in each case, the effect of which is such as to make it, in the sole judgment of UBS Financial Services Inc., impracticable for UBS Financial Services Inc. to sell Stock); or (C) a trading
suspension with respect to the Stock by the Securities and Exchange Commission or the Principal U.S. Market (defined in Exhibit A) or a delisting of the Stock or a banking moratorium has occurred; if UBS Financial Services Inc. cannot effect a sale
for any of such reasons, UBS Financial Services Inc. shall effect such sale as promptly as practical after the cessation or termination of such cause, subject to the restrictions set forth in paragraph 1 of Exhibit A; 

  

	 	(ii)	This Trading Plan is suspended in accordance with paragraph 7 below; 

  

	 	(iii)	This Trading Plan is terminated in accordance with paragraph 8 below; 

  

	5.	Rule 144 and Rule 145. With respect to sales of Stock subject to Rule 144 or Rule 145, Seller and UBS Financial Services Inc. agree to comply with the following
provisions: 

  

	 	(a)	Agreements by Seller Regarding Rule 144 and Rule 145. 

  

	 	(i)	Seller agrees not to take, and agrees to cause any person or entity with which Seller would be required to aggregate sales of Stock pursuant to Rule 144(a)(2) or (e) not to
take, any action that would cause the sales hereunder not to meet all applicable requirements of Rule 144 or Rule 145. 

  

	 	(ii)	 Seller agrees to complete, execute and deliver to UBS Financial Services Inc. Forms 144 for sales to be effected under the Trading Plan at such times and in such
numbers as UBS Financial Services Inc. shall request. Seller hereby grants UBS Financial Services Inc. a power of attorney to complete and file on behalf of Seller any required Forms 144. The remarks section of each Form 144 filed shall include a
statement to the effect that the shares covered by the Form 144 are being sold pursuant to a 

  

 3 

	 	 
Rule 10b5-l trading plan dated as of the date hereof, and the representation regarding the seller’s knowledge of material nonpublic information speaks
as of that plan adoption date. 

  

	 	(iii)	Seller agrees to complete, execute and deliver to UBS Financial Services Inc. Rule 144 Seller’s Representation Letters (in the form attached as Exhibit C) for sales to be
effected under the Trading Plan at such times and in such numbers as UBS Financial Services Inc. shall request. 

  

	 	(b)	Agreements by UBS Financial Services Inc. Regarding Rule 144 and Rule 145. 

  

	 	(i)	UBS Financial Services Inc. agrees to conduct all sales pursuant to the Trading Plan in accordance with the manner of sale requirement of Rule 144. UBS Financial Services Inc. shall
not effect any sales that it knows would exceed the then-applicable volume limitation under Rule 144. 

  

	 	(ii)	UBS Financial Services Inc. agrees to file such Forms 144 furnished by Seller pursuant to paragraph 5(a)(ii) on behalf of Seller as required by applicable law. UBS Financial
Services Inc. shall make one Form 144 filing at the beginning of each three-month period, commencing upon the first Sale Day under the Trading Plan. 

  

	 	(iii)	UBS Financial Services Inc. agrees to submit such Rule 144 Seller’s Representation Letters furnished by Seller pursuant to paragraph 5(a)(iii) on behalf of Seller as required
by Issuer’s transfer agent. 

  

	 	(iv)	Seller shall make and shall be solely responsible for all filings required under Sections 13(d) and 16 of the Exchange Act in connection with sales of Stock pursuant to the Trading
Plan, and Seller acknowledges that UBS Financial Services Inc. shall not make any such filings and shall have no liability to Seller in connection with or related to any such filings. 

  

	6.	Options. Seller and UBS Financial Services Inc. agree to the provisions regarding the exercise of Options contained in Exhibit D. 

  

	7.	Suspension. Sales under this Trading Plan shall be suspended as follows: 

  

	 	(a)	Promptly after the date on which UBS Financial Services Inc. receives notice from Seller or Issuer of legal, contractual or regulatory restrictions applicable to Seller or
Seller’s affiliates that would prevent UBS Financial Services Inc. from selling Stock under this Trading Plan (such notice merely stating that there is a restriction applicable to Seller without specifying the reasons for the restriction),
including a restriction based on Seller’s awareness of material nonpublic information in connection with a tender offer for Issuer’s securities (transactions on the basis of which Rule 14e-3 of the Exchange Act could be violated).

  

	 	(b)	In the event of a Qualifying Securities Offering, promptly after the date on which UBS Financial Services Inc. receives notice from Issuer or Seller of the Suspension Date until UBS
Financial Services Inc. receives notice from Issuer or Seller of the Resumption Date; provided, however, that (i) Seller certifies that Seller has no control over the Suspension Date or the Resumption Date, and (ii) if Seller is
unable to make such certification then this paragraph shall result in a termination of the Trading Plan, rather than suspension. 

  

 4 

 “Qualifying Securities Offering” means any offering of securities of Issuer for cash in which
the lead underwriter, lead manager, initial purchaser, placement agent or other entity performing a similar function (each, an “Underwriter”) requires Seller to agree to restrict Seller’s ability to effect Sales pursuant to this
Trading Plan. 
 “Suspension Date” means the date on which a preliminary prospectus, offering memorandum, offering circular or other
disclosure document (each, a “Preliminary Offering Document”) is first used to market securities of Issuer by the Underwriter, or if a Preliminary Offering Document is not used, the date on which the underwriting agreement, purchase
agreement, placement agent agreement or similar agreement (each, an “Underwriting Agreement”) is entered into by the Underwriter and Issuer. 
 “Resumption Date” means the day immediately following the expiration of the time period during which Seller was restricted from effecting Sales pursuant to this Trading Plan in accordance with the
Underwriting Agreement. 
  

	 	(c)	In the event that the UBS Financial Services Inc. 10b5-l Group becomes aware of material nonpublic information concerning Issuer or the Stock, UBS Financial Services Inc. may be
required by applicable law or, in its sole discretion, find it advisable, to suspend sales under this Trading Plan. In such case, UBS Financial Services Inc. shall promptly notify Seller of the suspension of sales under this Trading Plan.

  

	8.	Termination. This Trading Plan will terminate on the earliest to occur of the following (the “Plan Sales Period”): 

  

	 	(a)	at the close of trading on August 31, 2008; 

  

	 	(b)	promptly after the date on which UBS Financial Services Inc. receives notice from Seller of the termination of this Trading Plan, in which case, Seller agrees to notify the Issuer
promptly of such termination; 

  

	 	(c)	upon the reasonable determination by UBS Financial Services Inc., or promptly after the reasonable determination by Seller and notice to UBS Financial Services Inc., that this
Trading Plan does not comply with Rule 10b5-l; 

  

	 	(d)	promptly after the date UBS Financial Services Inc. is notified of the death of Seller, 

  

	 	(e)	immediately in the event that Seller fails to deliver any Stock pursuant to paragraph 4(b) or fails to satisfy the delivery requirements with respect to Options set forth in Exhibit
D; or 

  

	 	(f)	the date that the aggregate number of shares of Stock sold pursuant to this Trading Plan reaches 300,000 shares. 

  

 5 

	9.	Indemnification; Limitation of Liability. 

  

	 	(a)	Indemnification. 

  

	 	(i)	Seller agrees to indemnify and hold harmless UBS Financial Services Inc. and its directors, officers, employees and affiliates from and against all claims, losses, damages and
liabilities (including, without limitation, any legal or other expenses reasonably incurred in connection with defending or investigating any such action or claim) (collectively, “Losses”) arising out of or attributable to (A) UBS
Financial Services Inc.’s actions taken or not taken in compliance with this Trading Plan, (B) any breach by Seller of this Trading Plan (including Seller’s representations and warranties hereunder), or (C) any violation by
Seller of applicable laws or regulations. This indemnification shall survive termination of this Trading Plan. 

  

	 	(ii)	UBS Financial Services Inc. agrees to indemnify and hold harmless Seller from and against all Losses arising out of or attributable to the gross negligence or willful misconduct of
UBS Financial Services Inc. in connection with this Trading Plan. 

  

	 	(b)	Limitation of Liability. 

  

	 	(i)	Notwithstanding any other provision hereof, UBS Financial Services Inc. shall not be liable to Seller, and Seller shall not be liable to UBS financial Services Inc., for:
(A) special, indirect, punitive, exemplary or consequential damages, or incidental losses or damages of any kind, even if advised of the possibility of such losses or damages or if such losses or damages could have been reasonably foreseen; or
(B) any failure to perform or to cease performance or any delay in performance that results from a cause or circumstance that is beyond its reasonable control, including, but not limited to, failure of electronic or mechanical equipment,
strikes, failure of common carrier or utility systems, severe weather, market disruptions or other causes commonly known as “acts of God”. 

  

	 	(ii)	Notwithstanding any other provision hereof, UBS Financial Services inc. shall not be liable to Seller for (A) the exercise of discretionary authority or discretionary control
under this Trading Plan, if any, or (B) any failure to effect a sale required by paragraph 1, except for failures to effect sales as a result of the gross negligence or willful misconduct of UBS Financial Services Inc. 

 

	10.	Agreement to Arbitrate. Any dispute between Seller and UBS Financial Services Inc. arising out of, relating to or in connection with this Trading Plan or any
transaction relating to this Trading Plan shall be determined only by arbitration as provided in the UBS Financial Services Inc. brokerage account agreement referred to in paragraph 4(a). 

  

 6 

	11.	Notices. 

  

	 	(a)	All notices to UBS Financial Services Inc. under this Trading Plan shall be provided in writing to the Executive Services Group of UBS Financial Services Inc. by facsimile at fax
number 615-332-6809. 

  

	 	(b)	All notices to Seller under this Trading Plan shall be given to John D. Held by telephone at telephone number 713-940-6116, by facsimile at fax number 713- 940-6122 or by certified
mail to the address below: 

 2105 City West Blvd. 
 Suite 500 
 Houston, Texas 77042-2838 
  

	 	(c)	Seller hereby instructs and authorizes UBS Financial Services Inc. to send duplicate copies of all confirmations of trades made under this Trading Plan to the Issuer at the
following address: 

 Jude Brinkman 
 Omega Protein Corporation 
 2105 City West Blvd. 
 Suite 500 
 Houston, Texas 77042-2838

  

	 	(d)	UBS Financial Services Inc. will provide notification of all sales of Stock and exercise of Options under this Trading Plan to Seller and to Issuer by e-mail at the below addresses
by 6 p.m. (ET) on the date of execution on a best efforts basis, with a final report by 12 p.m. (ET) on the following business day. Seller and Issuer agree to notify UBS Financial Services Inc. in writing of any changes to the contact information
provided. 

 johndheld@msn.com 
 jbrinkman@omegaproteininc.com 
 doug.john@ubs.com 
  

	12.	Amendments and Modifications. This Trading Plan and the Exhibits hereto may be amended by Seller only upon the written consent of UBS Financial Services Inc. and
receipt by UBS Financial Services Inc. of the following documents, each dated as of the date of such amendment: 

  

	 	(a)	a certificate signed by Seller, certifying that the representations and warranties of Seller contained in this Trading Plan are true at and as of the date of such certificate as if
made at and as of such date; and 

  

	 	(b)	an issuer certificate completed by Issuer substantially in the form of Exhibit B. 

  

 7 

	13.	Inconsistency with Law. If any provision of this Trading Plan is or becomes inconsistent with any applicable present or future law, rule or regulation, that provision
will be deemed modified or, if necessary, rescinded in order to comply with the relevant law, rule or regulation. All other provisions of this Trading Plan will continue and remain in full force and effect. 

  

	14.	Governing Law. This Trading Plan shall be governed by and construed in accordance with the internal laws of the State of New York. 

  

	15.	Entire Agreement. This Trading Plan, including Exhibits, and the brokerage account agreement referred to in paragraph 4(a) above, constitute the entire agreement
between the parties with respect to this Trading Plan and supercede any prior agreements or understandings with regard to this Trading Plan. 

  

	16.	Counterparts. This Trading Plan may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and
hereto were upon the same instrument. 

 NOTICE: THIS AGREEMENT CONTAINS A PREDISPUTE ARBITRATION CLAUSE IN PARAGRAPH 10. 
 IN WITNESS WHEREOF, the undersigned have signed this Trading Plan as of the date first written above. 
  

									
	JOHN D. HELD	 		 	
				
	/s/ John D. Held	 		 		 	8/31/07
	Name:	 	John D. Held	 		 		 	Date
	Title:	 	General Counsel, Executive Vice President and Secretary	 		 		 	

  

 8 

									
	UBS FINANCIAL SERVICES INC.	 		 	
				
	 	 		 		 	 
	Name:	 	Doug Jones	 		 		 	Date
	Title:	 	Director	 		 		 	
				
	 	 		 		 	 
	Name:	 	Andrew Neal	 		 		 	Date
	Title:	 	Associate Director	 		 		 	

  

 9Sales Plan dated September 5, 2007

 Exhibit 10.3 
  

			
	 Issuer: Omega Protein Corporation
	 	Client: Joseph L. von Rosenberg III

 

 
 Corporate Equity Solutions Group 
 Preset Diversification ProgramSM (PDP) 
 Sales Plan 
 Sales Plan dated the date specified in Exhibit A hereto (this “Sales Plan”) between Seller specified in Exhibit A (“Seller”) and
Morgan Stanley & Co. Incorporated (“Morgan Stanley”), acting as agent for Seller. Capitalized terms used but not defined herein shall have the meaning given such terms in Exhibits A and B hereto. 
  

	A.	Recitals 

 1. This Sales Plan is entered into
between Seller and Morgan Stanley for the purpose of establishing a trading plan that complies with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). 
 2. Seller is establishing this Sales Plan in order to permit the orderly disposition of a portion of Seller’s holdings of common stock (the
“Stock”) of the Issuer, including (only if the Sales Plan covers Stock that Seller has the right to acquire under outstanding stock options as specified in Exhibit B hereto) Stock that Seller has the right to acquire under outstanding
stock options listed on Exhibit C (the “Options”) issued by the Issuer. 
  

	B.	Representations, Warranties and Covenants 

 1. As of the date hereof, Seller is not aware of any material nonpublic information concerning the Issuer or its securities. Seller is entering into this Sales Plan in good faith and not as part of a plan or scheme to evade compliance with
the federal securities laws. 
 2. The securities to be sold under this Sales Plan are owned free and clear by Seller (subject, in the case
of shares underlying Options (if Exhibit C is applicable), only to the compliance by Seller with the exercise provisions of such Options) and, as of the Selling Start Date, are not subject to any agreement granting any pledge, lien, mortgage,
hypothecation, security interest, charge, option or encumbrance or any other limitation on disposition, other than those which may have been entered into between Seller and Morgan Stanley or imposed by Rules 144 or 145 under the Securities Act of
1933, as amended (the “Securities Act”). 
 3. While this Sales Plan is in effect, Seller agrees not to enter into or alter any
corresponding or hedging transaction or position with respect to the securities covered by this Sales Plan (including, without limitation, with respect to any securities convertible or exchangeable into the Stock) and, unless this Sales Plan is
modified or terminated in accordance with the terms hereof, agrees not to alter or deviate from the terms of this Sales Plan. 
 4. Seller
agrees that Seller shall not, directly or indirectly, communicate any information relating to the Stock or the Issuer to any employee of Morgan Stanley or its affiliates who is involved, directly or indirectly, in executing this Sales Plan at any
time while this Sales Plan is in effect. Morgan Stanley represents that it has in place reasonable policies and procedures to ensure that any representative of Morgan Stanley effecting sales pursuant to this Sales Plan does not sell shares of Stock
on the basis of material non-public information. Any notice given to Morgan Stanley pursuant to this Sales Plan shall be given in accordance with paragraph F.4 below. 
 5. (a) Seller agrees to provide Morgan Stanley with a certificate dated as of the date hereof and signed by the Issuer substantially in the form of Exhibit D hereto prior to commencement of the Plan Sales Period (as
defined below). 
 (b) Seller agrees to notify Morgan Stanley’s PDP Trading Desk in writing at the address set forth in paragraph F.4
below as soon as practicable if Seller becomes aware of (i) a legal, contractual or regulatory restriction that is applicable to Seller or Seller’s affiliates or a stock offering requiring an affiliate lock-up, which would prohibit any
sale pursuant to the Sales Plan (other than any such restriction relating to Seller’s possession or alleged possession of material nonpublic information about the Issuer or its securities), (ii) a change in the Issuer’s insider
trading policies, so that the sales to be made by Morgan Stanley for the account of the Seller pursuant to the Sales Plan would violate these policies, or (iii) where the Sales Plan covers Stock that Seller has the right to acquire under
outstanding stock options, a change in the Issuer’s policies with regard to the timing or method of exercising such options which could interfere with the manner or timing of the sales to be made pursuant to this Sales Plan. In the case of a
notice relating to clause (i) above, such notice shall indicate the anticipated duration of the restriction, but shall not include any other information about the nature of the restriction or its applicability to Seller and shall not in any way
communicate any material nonpublic information about the Issuer or its securities to Morgan Stanley. Such notice shall be in addition to the notice required to be given to Morgan Stanley by the Issuer pursuant to the certificate set forth as Exhibit
D hereto. 
 6. Seller agrees to complete, execute and deliver to Morgan Stanley a seller representation letter dated as of the date hereof
substantially in the form of Exhibit E hereto prior to the commencement of the Plan Sales Period. 

 Preset Diversification Program is a registered service mark of Morgan Stanley & Co. Incorporated, protected in the United States and other countries. 
  

 1 

 7. The execution and delivery of this Sales Plan by Seller and the transactions contemplated by this
Sales Plan will not contravene any provision of applicable law or any agreement or other instrument binding on Seller or any of Seller’s affiliates or any judgment, order or decree of any governmental body, agency or court having jurisdiction
over Seller or Seller’s affiliates. 
 8. Seller has consulted with Seller’s own advisors as to the legal, tax, business, financial
and related aspects of this Sales Plan. Seller acknowledges that Morgan Stanley is not acting as its fiduciary but is acting in a brokerage capacity in connection with the adoption and implementation of this Sales Plan. 
 9. Seller agrees that until this Sales Plan has been terminated Seller shall not, without providing prior written notice to Morgan Stanley,
(i) enter into a binding contract with respect to the purchase or sale of Stock with another broker, dealer or financial institution (each, a “Financial Institution”), (ii) instruct another Financial Institution to purchase or
sell Stock or (iii) adopt a plan for trading with respect to Stock other than this Sales Plan. 
 10. (a) Seller agrees to make (or
cause to be made) all filings, if any, required under Sections 13(d), 13(g) and 16 of the Exchange Act in a timely manner, to the extent any such filings are applicable to Seller. 
 (b) Seller agrees that Seller shall at all times during the Plan Sales Period (as defined below), in connection with the performance of this Sales Plan,
comply with all applicable laws, including, without limitation, Section 16 of the Exchange Act and the rules and regulations promulgated thereunder. 
 (c) Seller agrees to complete, execute and deliver to Morgan Stanley a Section 16 Authorization Letter in the form attached hereto as Exhibit F. 
 11. Seller acknowledges and agrees that Seller does not have, and shall not attempt to exercise, any influence over how, when or whether to effect sales
of Stock pursuant to this Sales Plan. Seller and Morgan Stanley acknowledge and agree that Morgan Stanley shall not sell Stock pursuant to this Sales Plan at any time when any person at Morgan Stanley executing such sales is aware of material
nonpublic information concerning the Issuer or its securities. 
 12. (a) Seller represents that Seller is not entering into the Sales Plan
on behalf of, or with the assets of, an individual retirement account or individual retirement annuity, or any employee retirement or employee benefit plan (such as, for example, a Keogh or “HR-10” plan). [Explanatory Note: A Sales Plan
involving the sale of stock acquired through the exercise of employee stock options would not be “on behalf of, or with the assets of’ any of the types of plans referred to in this sub-paragraph.] 
 (b) If Seller is not an individual, Seller represents that Seller is not an “employee benefit plan” within the meaning of Section 3(3) of
the Employee Retirement Income Security Act of 1974, as amended, or a “plan” as defined under Section 4975(e) of the Internal Revenue Code of 1986, as amended, or an entity whose underlying assets include the assets of any such plan
by reason of such a plan’s investment in such entity. 
 13. If the Stock is to be sold pursuant to Rule 144 or 145 of the Securities
Act (as indicated by Seller in Exhibit A hereto), Seller makes the following additional representations, warranties and agreements: 
 (a)
Seller represents and warrants that the Stock to be sold pursuant to this Sales Plan is currently eligible for sale under Rule 144 or 145. 
 (b) Seller agrees not to take, and agrees to cause any person or entity with which Seller would be required to aggregate sales of Stock pursuant to paragraph (a)(2) or (e) of Rule 144 not to take, any action that would cause the sales
hereunder not to meet all applicable requirements of Rule 144. 
 (c) Seller agrees to complete, execute and deliver to Morgan Stanley Forms
144 for the sales to be effected under this Sales Plan at such times and in such numbers as Morgan Stanley shall request, and Morgan Stanley agrees to file such Forms 144 on behalf of Seller as required by applicable law. The “Remarks”
section of each Form 144 shall bear a notification which states that the Stock covered by such Form 144 is being sold pursuant to this Sales Plan and that the representation regarding Seller’s knowledge of material nonpublic information speaks
as of the date that Seller adopted this Sales Plan. If Exhibit A indicates that the Stock is to be sold pursuant to Rule 144 or 145 of the Securities Act, Seller agrees that Morgan Stanley shall continue making Form 144 filings as contemplated by
this paragraph B.13(c) in connection with sales under this Sales Plan until Morgan Stanley receives a written notification (which notification shall be acknowledged by the Issuer) stating that Seller is no longer an “affiliate” of the
Issuer as that term is defined under Rule 144. 
 (d) Seller hereby grants Morgan Stanley a power of attorney to complete and/or file on
behalf of Seller any required Forms 144. Notwithstanding such power of attorney, Seller acknowledges that Morgan Stanley shall have no obligation to complete or file Forms 144 on behalf of Seller except as set forth in subparagraph (c). 

 14. Morgan Stanley agrees to conduct all sales pursuant to this Sales Plan
in accordance with the manner of sale and current public information requirements of Rule 144 and in no event shall Morgan Stanley effect any sale if such sale would exceed the then-applicable amount limitation under Rule 144, assuming Morgan
Stanley’s sales pursuant to this Sales Plan are the only sales subject to that limitation. 
  

 2 

 15. As of the date hereof, Seller has not received notice of the imposition of, and Seller is not
otherwise aware of the actual or approximate beginning or ending dates of, any existing or impending “blackout period” pertaining to the Issuer’s securities in individual account plans maintained by the Issuer, as defined by Rule
100(b) of Regulation Blackout Trading Restriction (“Regulation BTR”) issued by the Securities and Exchange Commission (the “SEC”), and any amendments thereto. 
  

	C.	Implementation of the Plan 

 1. Seller hereby
appoints Morgan Stanley to sell shares of Stock pursuant to the terms and conditions set forth below. Subject to such terms and conditions, Morgan Stanley hereby accepts such appointment. 
 2. Morgan Stanley is authorized to begin selling Stock pursuant to this Sales Plan on the Selling Start Date and shall cease selling Stock on the
earliest to occur of (i) the date on which Morgan Stanley is required to suspend or terminate sales under this Sales Plan pursuant to paragraph D.3 below, (ii) if Seller is an individual, the date on which Morgan Stanley receives notice of
the death of Seller, (iii) the date on which Morgan Stanley receives notice of the commencement or impending commencement of any proceedings in respect of or triggered by Seller’s bankruptcy or insolvency, (iv) the date on which
Morgan Stanley receives a valid Customer Securities Account Transfer notice with respect to the account of Seller, and (v) the Selling End Date (the “Plan Sales Period”). 
 3. (a) Morgan Stanley shall sell the Interim Sale Amount specified in Exhibit B for the account of Seller during each Interim Sales Period specified in
Exhibit B at Morgan Stanley’s sole discretion in accordance with ordinary principles of best execution; provided, that Morgan Stanley shall not sell any shares of Stock pursuant to this Sales Plan at a price of less than the Minimum Sale
Price specified in Exhibit B; and provided, further, that, except as otherwise provided in Exhibit B hereto, Morgan Stanley shall not sell any shares of Stock pursuant to this Sales Plan to the extent that such sales would, on any given day,
constitute over 25% of the total trading volume on any such day, as reasonably estimated by Morgan Stanley at such time. 
 A “Trading
Day” is any day during the Plan Sales Period that the primary market on which the Stock regularly trades is open for business and the Stock trades regular way on such market. 
 (b) The Interim Sale Amount, the Total Sale Amount and the Minimum Sale Price (to the extent any such terms are applicable) and any other share amounts
and per share prices set forth in paragraph C of this Sales Plan shall be adjusted automatically on a proportionate basis to take into account any stock split, reverse stock split or stock dividend with respect to the Stock or any change in
capitalization with respect to the Issuer that occurs during the Plan Sales Period. 
 4. Morgan Stanley shall not sell Stock hereunder at
any time when: 
 (i) Morgan Stanley, in its sole discretion, has determined that a market disruption, material disruption in securities
settlement, payment or clearance services, banking moratorium, outbreak or escalation of hostilities or other crisis or calamity that could, in Morgan Stanley’s judgment, impact offer, sales or delivery of the Stock has occurred (provided,
however, that Morgan Stanley shall resume effecting trades in accordance with this Sales Plan as soon as Morgan Stanley determines that it is reasonably practical to do so); or 
 (ii) Morgan Stanley, in its sole discretion, has determined that it is prohibited from doing so by a legal, contractual or regulatory restriction
applicable to it or its affiliates or to Seller or Seller’s affiliates (other than any such restriction relating to Seller’s possession or alleged possession of material nonpublic information about the Issuer or the Stock); or 

(iii) Morgan Stanley has received notice from the Issuer or Seller of the occurrence of any event contemplated by paragraph B.5(b) above; or

 (iv) Morgan Stanley has received notice from Seller to terminate the Sales Plan in accordance with paragraph D.3 below. 
 5. (a) Seller agrees to deliver the Stock to be sold pursuant to this Sales Plan (with the amount to be estimated by Seller in good faith, if the Interim
Sale Amount is designated as an aggregate dollar amount) (the “Plan Shares”), to the extent such Plan Shares are currently owned by Seller, into an account at Morgan Stanley in the name of and for the benefit of Seller (the “Plan
Account”) prior to the commencement of sales under this Sales Plan. 
 Morgan Stanley agrees to notify Seller promptly if at any time
during the Plan Sales Period the number of shares of Stock so delivered to the Plan Account is less than the number of Plan Shares remaining to be sold pursuant to this Sales Plan (not including shares of Stock underlying the Options described in
subparagraph (b) below). Upon such notification, Seller agrees to deliver promptly to the Plan Account the number of shares of Stock necessary to eliminate this shortfall. 
 (b) If the Sales Plan covers Options and Exhibit C is applicable, Seller agrees to make appropriate arrangements with the Issuer and its transfer agent
and stock plan administrator to permit Morgan Stanley to furnish notice to the Issuer of the exercise of the Options and to have underlying shares delivered to Morgan Stanley as necessary to effect sales under this Sales Plan. Seller hereby
authorizes Morgan Stanley to serve as Seller’s agent and attorney-in-fact and, in accordance with the terms of this Sales Plan, to exercise the Options. Seller agrees to complete, execute and 

  

 3 

 
deliver to Morgan Stanley Stock Option Cashless Exercise Forms, in the form attached hereto as Exhibit G, for the exercise of Options pursuant to this Sales
Plan at such times and in such numbers as Morgan Stanley shall request. Stock received upon exercise of Options shall be delivered to the Plan Account. 
 (c) Morgan Stanley shall withdraw Stock from the Plan Account in order to effect sales of Stock under this Sales Plan. 
 If the Sales Plan covers Options and Exhibit C is applicable, and on any day that sales are to be made under this Sales Plan the number of shares of Stock in the Plan Account is less than the number of shares to be
sold on such day, Morgan Stanley shall exercise a sufficient number of Options to effect such sales in the manner specified in Exhibit C under “Manner of Exercising Options”. Morgan Stanley shall in no event exercise any Option if at the
time of exercise the exercise price of the Option is equal to or higher than the market price of the Stock. Morgan Stanley shall, in connection with the exercise of Options, remit to the Issuer the exercise price thereof along with such amounts as
may be necessary to satisfy withholding obligations. These amounts shall be deducted from the proceeds of sale of the Stock, together with interest thereon computed in accordance with Morgan Stanley’s customary practices. 
 (d) To the extent that any Stock remains in the Plan Account after the end of the Plan Sales Period or upon termination of this Sales Plan, Morgan
Stanley agrees to return such Stock promptly to the Issuer’s transfer agent for relegending to the extent that such Stock would then be subject to transfer restrictions in the hands of the Seller. 
 6. Morgan Stanley shall in no event effect any sale under this Sales Plan if the Stock to be sold is not in the Plan Account or underlying an Option that
is exercised in accordance with the terms of this Sales Plan on the day of such sale. 
 7. Morgan Stanley may sell Stock on any national
securities exchange, in the over-the-counter market, on an automated trading system or otherwise. Seller agrees that if Morgan Stanley is a market maker or dealer in the Stock at the time that any sale is to be made under this Sales Plan, Morgan
Stanley may, at its sole discretion, purchase the Stock from Seller in its capacity as market maker or dealer. 
 8. All references in this
Sales Plan to per share stock prices shall be before deducting any commission, commission equivalent, mark-up or differential and other expenses of sale. 
 9. Seller may instruct Morgan Stanley to sell or purchase shares of Stock other than pursuant to this Sales Plan. The parties hereto agree that any such sale or purchase transaction (i) will not be deemed to
modify this Sales Plan unless Seller so requests in writing in accordance with paragraph D.1 below and (ii) will be given by Seller to Morgan Stanley only if such transaction does not contravene any of the representations, warranties or
covenants set forth in Section B of this Sales Plan. 
  

	D.	Amendment; Termination 

 1. This Sales Plan
may be amended by Seller only upon the written consent of Morgan Stanley and receipt by Morgan Stanley of the following documents, each dated as of the date of such amendment: 
 (i) a representation signed by the Issuer substantially in the form of Exhibit D hereto, 
 (ii) a certificate signed by Seller certifying that the representations and warranties of Seller contained in this Sales Plan are true at and as of the
date of such certificate as if made at and as of such date, and 
 (iii) a seller representation letter completed and executed by Seller
substantially in the form of Exhibit E hereto. 
 2. In no event may Seller modify or otherwise alter this Sales Plan if Seller has received
notice of the imposition of, or Seller is otherwise aware of the actual or approximate beginning or ending dates of, any existing or impending “blackout period” pertaining to the Issuer’s securities in individual account plans
maintained by the Issuer, as defined by Rule 100(b) of Regulation BTR issued by the SEC, and any amendments thereto. 
 3. (a) This Sales
Plan may be suspended or terminated by Seller at any time upon one days prior written notice sent to Morgan Stanley’s PDP Trading Desk by overnight mail or by facsimile at the address and fax number set forth in paragraph F.4 below. Seller
agrees that Seller shall not suspend or terminate this Sales Plan except upon consultation with Seller’s own legal advisors. 
 (b) This
Sales Plan shall be suspended or, at Morgan Stanley’s option, terminated, if Morgan Stanley receives notice from the Issuer of the occurrence of any event contemplated by paragraph 3 of the certificate set forth as Exhibit D hereto. 

4. Seller agrees that Morgan Stanley will execute this Sales Plan in accordance with its terms and will not be required to suspend or terminate any
sales of the Stock unless Morgan Stanley has received notice from Seller or the Issuer in accordance with paragraph D.3 above at least one day prior to the date on which this Sales Plan is to be suspended or terminated. 
  

	E.	Indemnification; Limitation of Liability 

 1.
(a) Seller agrees to indemnify and hold harmless Morgan Stanley and its directors, officers, employees and affiliates from and against all claims, losses, damages and liabilities (including, without limitation, any legal or other expenses reasonably
incurred in connection with defending or 

  

 4 

 
investigating any such action or claim) (collectively, “Losses”) arising out of or attributable to this Sales Plan, including, without limitation,
any breach by Seller of this Sales Plan (including Seller’s representations and warranties hereunder) or any violation by Seller of applicable laws or regulations; provided, however, that the indemnification provisions of this paragraph E.1.(a)
shall not apply in the case of any claims, losses, damages or liabilities resulting from Morgan Stanley’s gross negligence or willful misconduct. Seller will reimburse Morgan Stanley for any and all advance fees, costs and expenses of any kind
incurred by Morgan Stanley as a result of such Losses. This indemnification shall survive termination of this Sales Plan. 
 (b)
Notwithstanding any other provision hereof, neither party shall be liable to the other for: 
 (i) any special, indirect,
punitive, exemplary or consequential damages, or incidental losses or damages of any kind, even if advised of the possibility of such losses or damages or if such losses or damages could have been reasonably foreseen, or 
 (ii) any failure to perform or to cease performance or any delay in performance that results from a cause or circumstance that is beyond
its reasonable control, including but not limited to failure of electronic or mechanical equipment, strikes, failure of common carrier or utility systems, outbreak or escalation of hostilities or other crisis or calamity, severe weather, market
disruptions, material disruptions in securities settlement, payment or clearance services or other causes commonly known as “acts of God”. 
  

	F.	General 

 1. Proceeds from each sale of Stock
effected under the Sales Plan will be delivered to the account of Seller less any commission, commission equivalent, mark-up or differential and other expenses of sale to be paid to Morgan Stanley, provided that any commission hereunder shall be as
specified in Exhibit B. 
 2. Seller and Morgan Stanley acknowledge and agree that this Sales Plan is a “securities contract,” as
such term is defined in Section 741(7) of Title 11 of the United States Code (the “Bankruptcy Code”), entitled to all of the protections given such contracts under the Bankruptcy Code. 
 3. This Sales Plan constitutes the entire agreement between the parties with respect to this Sales Plan and supercedes any prior agreements or
understandings with regard to the Sales Plan. 
 4. All notices to Morgan Stanley under this Sales Plan shall be given to Morgan
Stanley’s PDP Administration Unit in the manner specified by this Sales Plan by facsimile at 201-200-2979 or by certified mail to the address below: 
 Morgan Stanley & Co. Incorporated 
 Harborside Financial Center 
 Plaza III, 1st Floor 
 Jersey City, NJ 07311 
 Attn: PDP Administration Services 
 5. Seller’s rights and obligations under this Sales Plan may not be
assigned or delegated without the written permission of Morgan Stanley. 
 6. This Sales Plan may be signed in any number of counterparts,
each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. 
 7. If any
provision of this Sales Plan is or becomes inconsistent with any applicable present or future law, rule or regulation, that provision will be deemed modified or, if necessary, rescinded in order to comply with the relevant law, rule or regulation.
All other provisions of this Sales Plan will continue and remain in full force and effect. 
 8. This Sales Plan shall be governed by and
construed in accordance with the internal laws of the State of New York and may be modified or amended only by a writing signed by the parties hereto. 
  

 5 

 IN WITNESS WHEREOF, the undersigned have signed
this Sales Plan on the date specified below1 2.

  

			
	SELLER
		
	By:	 	 /s/ Joseph L. von Rosenberg

	Name:	 	Joseph L. von Rosenberg III
	Date:	 	September 5, 2007
	
	MORGAN STANLEY & CO. INCORPORATED
		
	By:	 	  

	Name:	 	Richard J. Fischer
	Title:	 	Vice President
	Date:	 	

	 1
	 Seller is advised that Morgan Stanley’s obligations under this Sales Plan
will not take effect unless and until this Sales Plan is approved and executed by Morgan Stanley. 

	 2
	 Note: If this Sales Plan involves the sale of stock that is restricted under Rule
144 and/or Section 16, Morgan Stanley may not execute this Sales Plan until the firm’s standard restricted stock due diligence process for such securities has been completed. 

  

 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}]]